ContractIndemnification Agreement • December 2nd, 2016 • Stocosil Inc. • Pharmaceutical preparations • Delaware
CONSULTING & COORDINATION RETAINER AGREEMENT:Consulting & Coordination Retainer Agreement • December 2nd, 2016 • Stocosil Inc. • Pharmaceutical preparations • California
Stocosil Inc., a Delaware corporation with an address of 17870 Castleton St., Ste. 250, City of Industry, CA 91765 (“Company”), is intending to engage in a public offering of securities pursuant to an exemption from registration pursuant to Section 3(b) of the Securities Act of 1933, as amended (the “Act”) and Regulation A+ promulgated thereunder (the “Offering”). Both parties may be hereinafter referred to each individually as a “Party” and collectively as the “Parties”. This Agreement supersedes and replaces any and all prior agreements between the parties.
PRODUCT DEVELOPMENT, LICENCE AND COMMERCIALIZATION AGREEMENTProduct Development, Licence and Commercialization Agreement • December 2nd, 2016 • Stocosil Inc. • Pharmaceutical preparations
This Product Development, Licence and Commercialization Agreement (“Agreement”) is made and entered into as of February 27th, 2015 by and between Daewoong Pharmaceuticals Co. Ltd. a company incorporated under the laws of South Korea and having its registered office at 163-3, Samsung-Dong, Kangnam-Gu, Seoul, Korea (“DAEWOONG”) and Autotelic, LLC and Autotelic, Inc., and Stocosil Inc. (“STOCOSIL”) companies incorporated under the laws of Delaware, having its registered office at 17870 Castleton Street, Ste. 250, City of Industry, CA 91748, USA. (“STOCOSIL”).
